Key clinical message
In this case report we present a very rare case of intramuscular cavernous hemangioma in the temporalis muscle which was successfully managed with surgical excision with no evidence of recurrence in follow‐up.
Keywords: cavernous hemangioma, intramuscular, temporalis muscle
Intra‐operative image showing the lesion in the caudal aspect of the temporalis muscle.
1. INTRODUCTION
Vascular malformations are a diverse group of pathologic lesions. The most common types of vascular malformations are capillary telangiectasias, cavernous malformations, venous malformations, and arteriovenous malformations. 1 Hemangiomas are benign neoplasms with vascular origin typically located in skin or subcutaneous tissues. They represent 7% of all nonmalignant soft tissue neoplasms. Less than 1% of hemangiomas arise from the muscular structures. The most commonly involved areas are large skeletal muscles of the lower extremities and only 10% of intramuscular hemangiomas are located in the head and neck area. 2 Moreover, the most common site of intramuscular hemangioma in the head and neck is the masseter muscle, and temporalis muscle involvement is rare. 3 Thus, presentation of this pathologic lesion in the temporal area might be largely confusing in the clinical practice. Here, successful diagnosis and management of a case of an intramuscular cavernous hemangioma (ICH) of the temporalis muscle is reported.
2. CASE HISTORY
A 51‐year‐old female was admitted to the oral and maxillofacial surgery department of a tertiary university hospital in August 2019, complaining about the presence of a mass in her left temporal area (Figure 1). The patient had noticed the lesion since 10 years ago and reported a slight gradual increase in its size, but she preferred not to seek any medical consultation because the mass was painless. The patient reported a mild unpleasant feeling of pressure while talking or chewing food. She presented no history of trauma to the region. The patient only reported a history of pregnancy followed by a cesarean section 27 years ago and the past medical history, familial history, and drug history of the patient were otherwise, unremarkable.
FIGURE 1.
Pre‐operative image of the patient showing a bulk in her left temporalis muscle.
Clinical examination revealed a rubbery, compressible, painless, immobile, dome‐shaped mass of 2.5 cm in diameter, above the left zygomatic arch. No pulsation or bruit was detected and the overlying skin was normal with no signs of erythema or warmth. The mass became slightly more apparent when the patient clenched her jaw but there was no clear change in the size of the lesion with Valsalva maneuver. Mandibular movements were within normal range and not restricted. Neurologic examination of cranial nerves was also normal. No adenopathy was found in the face and neck area examination.
For radiologic examination, computed tomography(CT) scan of the lesion showed a well‐defined soft tissue mass in the temporal region with no bony erosion or invasion (Figure 2). Subsequently, a magnetic resonance image(MRI) was acquired which displayed a 24 × 12 mm high‐intensity signal lesion on T1 and T2‐weighted images, with lobulated borders and linear low‐intensity internal structures in the anterior inferior aspect of the temporalis muscle (Figure 3). These findings were suggestive of an angiomatous lesion. The patient declined further angiographic examinations due to financial reasons.
FIGURE 2.
Computed tomography scan showing a mass lesion in the left temporalis muscle.
FIGURE 3.
Axial (above) and coronal (below) T2 sequence magnetic resonance imaging showing a high‐intensity lesion within the left temporalis muscle.
After acquiring informed consent, the patient underwent full surgical excision of the lesion under general anesthesia. Al‐Kayat Bramley incision 4 was used for comprehensive access to the lesion and avoiding visible scar while preserving temporal branches of the facial nerve (Figures 4,, 5). Intraoperative examination revealed a lobulated soft to elastic blueish‐red mass in the temporalis muscle above the zygomatic arch without any invasion to the surrounding structures. Enlarged vascular structures were revealed in the inferior aspect of the lesion after surgical dissection which were ligated. The postoperative clinical course was eventless and there was no temporary or permanent weakness of the facial nerve.
FIGURE 4.
Intra‐operative image showing the lesion in the caudal aspect of the temporalis muscle.
FIGURE 5.
Clinical image of the gross lesion after excision.
Gross pathologic examination showed one piece of lobular encapsulated grayish‐brown soft to elastic tissue measuring 3 × 2.5 × 1.5 cm with variable‐sized cystic spaces filled by fragile brown material. Histologic examination of the lesion revealed a vascular lesion consisting of numerous large endothelium‐lined vessels with intraluminal papillary projections, sinusoidal, and anastomosing vessels in a fibrotic stroma. Intravascular thrombosis, adipose tissue, and patchy inflammatory cell infiltration were also seen (Figure 6). There was no sign of malignancy. The final diagnosis was intra‐muscular cavernous malformation.
FIGURE 6.
Microscopic image showing multiple large vessels in a fibrotic stroma.
The patient was followed up periodically for up to 2 years with no sign of recurrence and no limitation in mandibular movements.
3. DISCUSSION
There are very few reported cases of intramuscular hemangioma in the temporalis muscle with the first cases dating back to the 1950s. 5
Unlike the common subcutaneous types of hemangioma, intramuscular hemangioma is not present at birth, is usually detected in the second or third decades of life, tends to grow slowly and progressively, and does not show spontaneous regression. Although the masseter muscle is the most common site of intramuscular hemangioma of the head region, 6 this lesion has been reported in other facial muscles such as the zygomatic, 7 buccinator, 8 extraocular, 9 and temporalis muscle. 10
Hemangiomas are divided into five common categories based on their predominant histologic vasculature: capillary (small vessel), cavernous (large vessel), arteriovenous, venous, and mixed. 11 Cavernous hemangiomas, also called cavernous malformations, are clusters of abnormally dilated and cyst‐like capillary structures with flattened endothelium, whereas capillary hemangiomas consist of highly cellular small‐sized vessels. Cavernous hemangiomas tend to grow slower so the patient usually notes a longer history of the lesion. 12
In a literature review by Alqahtani et al. 13 on 33 temporalis muscle hemangioma cases reported until 2022, 18/33 patients were males indicating an almost even gender distribution. Besides trauma, hormonal factors are also cited as potential etiologic entities, especially with existing evidence indicating stable or regressing lesions in postmenopausal female patients. 14 Despite this, there is still controversy regarding the role of estrogen and progesterone receptors in the development of cavernous hemangiomas. 15 , 16
These lesions can easily be diagnosed by MRI with typical hypersignal images on T2 and hypo‐to‐iso signal images on T1 sequences. 17 Any form of biopsy could potentially lead to substantial bleeding as well as yielding inadequate specimen and therefore is not recommended.
Although many consider surgery as the best treatment option for intramuscular hemangiomas of the temporalis muscle, 18 , 19 some recommend it, only if the patient has cosmetic complaints or the lesion is suspected to be capillary hemangioma which is more likely to be infiltrative and recurrent. 20 On clinical grounds, this can be suspected by a lack of Valsalva dependence of lesion dimension changes or radiologic signs. During surgical excision, care should be given to spare facial nerve branches. Our patient had neither Valsalva dependence nor was she cosmetically satisfied with her appearance and therefore we decided to proceed with complete surgical excision. In accord with the successful surgical management of these lesions reported by previous studies, our patient was cured as well with no evidence of recurrence or surgery‐associated adverse events with 2 years of follow‐up. Other treatment options for intramuscular hemangiomas include embolization, 21 corticosteroids, 22 beta‐blockers, 23 and radiation therapy 24 although with variable responses and seemingly inferior to definitive surgery as none of these methods removes the lesion completely.
Following the experience with the present case and a few others reported in the literature, it is recommended to consider intramuscular hemangioma in the differential diagnosis of isolated pathologic lesions of facial muscles when radiologic and clinical symptoms are in accord with a benign neoplasm of vascular origin. Surgical treatment is generally successful with very low rates of recurrence.
4. CONCLUSION
In this article, we reported a rare case of intramuscular cavernous malformation in the temporalis muscle; an unusual site with very few cases reported in the literature. The patient was successfully treated with complete surgical excision of the lesion with preservation of the facial nerve branches. There is no evidence of disease recurrence or treatment‐related adverse events with 2 years of follow
AUTHOR CONTRIBUTIONS
Mohammad Jafarian: Conceptualization; data curation; project administration; supervision; validation; writing – original draft; writing – review and editing. Mohammad Amir Alizadeh Tabrizi: Conceptualization; data curation; project administration; resources; writing – original draft; writing – review and editing. Fatemeh Mashhadi Abbas: Data curation; resources; supervision; writing – original draft; writing – review and editing. Zahra Sadat Torabi: Conceptualization; data curation; investigation; project administration; resources; writing – original draft; writing – review and editing.
FUNDING INFORMATION
None.
CONFLICT OF INTEREST STATEMENT
None.
ETHICS STATEMENT
Our study was performed in line with the principles of the Declaration of Helsinki. The subject signed informed consent and patient anonymity was preserved.
CONSENT
Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.
Jafarian M, Alizadeh Tabrizi MA, Mashhadi Abbas F, Torabi ZS. Intramuscular cavernous malformation in the temporalis muscle: Diagnosis and treatment of a rare tumor in a rare site. Clin Case Rep. 2023;11:e8267. doi: 10.1002/ccr3.8267
Contributor Information
Mohammad Jafarian, Email: drmjaf@outlook.com.
Mohammad Amir Alizadeh Tabrizi, Email: amiralizadetabrizi86@gmail.com.
Fatemeh Mashhadi Abbas, Email: fmashhadiabbas@yahoo.com.
Zahra Sadat Torabi, Email: ztorabie@yahoo.com.
DATA AVAILABILITY STATEMENT
Research data are stored in an institutional repository and will be shared upon request to the corresponding author.
REFERENCES
- 1. Carqueja IM, Sousa J, Mansilha A. Vascular malformations: classification, diagnosis and treatment. Int Angiol. 2018;37(2):127‐142. [DOI] [PubMed] [Google Scholar]
- 2. Enzinger FM, Weiss SW. Soft tissue tumors. St Louis CV Mosby. 1988;202:512‐515. [Google Scholar]
- 3. Weiss SW, Goldblum JR, Folpe AL. Enzinger and Weiss's Soft Tissue Tumors. Elsevier Health Sciences; 2007. [Google Scholar]
- 4. Al‐Kayat A, Bramley P. A modified pre‐auricular approach to the temporomandibular joint and malar arch. British J Oral Surg. 1979;17(2):91‐103. [DOI] [PubMed] [Google Scholar]
- 5. Scott JE. Haemangiomata in skeletal muscle. Br J Surg. 1957;44(187):496‐501. [DOI] [PubMed] [Google Scholar]
- 6. Nayak S, Shenoy A. Intra‐muscular hemangioma: a review. J Orofac Sci. 2014;6(1):2‐4. [Google Scholar]
- 7. Aloyouny AY, Mehanny MS, Albagieh HN, Alfaleh WM, Mansour SM, Mobarak FA. Intramuscular hemangioma in the zygomaticus muscle: a rare case report presentation and diagnosis. Int J Surg Case Rep. 2020;74:42‐45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Doddanna SJ, Dawar G, Rallan NS, Agarwal M. Intramuscular cavernous hemangioma: a rare entity in the buccinator muscle. Indian J Dent Res. 2014;25(6):813‐815. [DOI] [PubMed] [Google Scholar]
- 9. Tabuenca Del Barrio L, Gasparini C, Devoto MH. Intramuscular cavernous venous malformation of extraocular muscles. Fractionated stereotactic radiotherapy as a therapeutic alternative. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(6):293‐296. [DOI] [PubMed] [Google Scholar]
- 10. Kishimoto T, Sukegawa S, Katase N, et al. Endoscope‐assisted resection of intramuscular cavernous hemangioma within the temporal muscle. J Craniofac Surg. 2019;30(1):193‐195. [DOI] [PubMed] [Google Scholar]
- 11. Allen PW, Enzinger FM. Hemangioma of skeletal muscle. An analysis of 89 cases. Cancer. 1972;29(1):8‐22. [DOI] [PubMed] [Google Scholar]
- 12. Beham A, Fletcher CD. Intramuscular angioma: a clinicopathological analysis of 74 cases. Histopathology. 1991;18(1):53‐59. [DOI] [PubMed] [Google Scholar]
- 13. Alqahtani AA, AlQarni AA, Abbas MM, Alkhani AM. Temporal muscle cavernous hemangioma: a case report and literature review. Cureus. 2022;14(3):e23166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Jayaram A, Lissner GS, Cohen LM, Karagianis AG. Potential correlation between menopausal status and the clinical course of orbital cavernous hemangiomas. Ophthalmic Plast Reconstr Surg. 2015;31(3):187‐190. [DOI] [PubMed] [Google Scholar]
- 15. Kaya AH, Ulus A, Bayri Y, et al. There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study. Surg Neurol. 2009;72(3):263‐265. [DOI] [PubMed] [Google Scholar]
- 16. Reggiani Bonetti L, Boselli F, Lupi M, et al. Expression of estrogen receptor in hemangioma of the uterine cervix: reports of three cases and review of the literature. Arch Gynecol Obstet. 2009;280(3):469‐472. [DOI] [PubMed] [Google Scholar]
- 17. Montoya F, Vidal A, Sepulveda F, Marileo R, Caro J, Castillo M. Cavernous sinus hemangioma: imaging diagnosis and surgical considerations. World Neurosurg. 2021;146:e30‐e37. [DOI] [PubMed] [Google Scholar]
- 18. Cappabianca P, Cirillo S, de Divitiis E, de Caro MB, Spaziante R, Zona G. Hemangioma of the temporal muscle. Head Neck. 1996;18(2):197‐200. [DOI] [PubMed] [Google Scholar]
- 19. Knox RD, Pratt MF, Garen PD, Giles WC. Intramuscular hemangioma of the infratemporal fossa. Otolaryngol Head Neck Surg. 1990;103(4):637‐641. [DOI] [PubMed] [Google Scholar]
- 20. Heckl S, Aschoff A, Kunze S. Cavernous hemangioma of the temporal muscle. Neurosurg Rev. 2002;25(1–2):63‐65. [DOI] [PubMed] [Google Scholar]
- 21. Li GW, Zhao ZR, Li BS, Liu XG, Wang ZL, Liu QF. Source of blood supply and embolization treatment in cavernous hemangioma and sclerosis of the liver. World J Gastroenterol. 1997;3(3):147‐149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Dourmishev LA, Dourmishev AL. Craniofacial cavernous hemangioma: successful treatment with methylprednisolone. Acta Dermatovenerol Alp Pannonica Adriat. 2005;14(2):49‐52. [PubMed] [Google Scholar]
- 23. Ramdhani D, Seedat RY. Recurrent parotid cavernous haemangioma in an adolescent, successfully treated with propranolol. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(5S):S117‐S119. [DOI] [PubMed] [Google Scholar]
- 24. Gaspar L, Mascarenhas F, da Costa MS, Dias JS, Afonso JG, Silvestre ME. Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiother Oncol. 1993;29(1):45‐50. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Research data are stored in an institutional repository and will be shared upon request to the corresponding author.